UniQure Investors

38 investors on Angel Roster list UniQure in their portfolio. Most are venture capital firms and venture debt lenders, the most common stage is Seed and the largest groups are based in the United States, the Netherlands and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name UniQure can appear together.

Investors listed
38
With verified email
37%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 38 UniQure investors

The most complete profiles first. Showing 38 of 38.

  • Antoine BoulangerVerified

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Anastasia KarpovaVerified

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • April YoungVerified

    Venture Debt · United States

    Health CareDatabasesWomen FoundedEnterprise Software

    Portfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more

    Contact details available

  • Greg PetersonVerified

    Venture Capital, Venture Debt · United States

    Health CareDatabasesWomen FoundedEnterprise Software

    Portfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more

    Verified email available

  • Janice BourqueVerified

    Venture Capital, Venture Debt · United States

    Health CareDatabasesWomen FoundedEnterprise Software

    Portfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more

    Verified email available

  • John MontanaVerified

    Venture Capital, Private Equity Firm, Investment Partner · United Kingdom

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Melanie GraceVerified

    Venture Debt · United States

    Health CareDatabasesWomen FoundedEnterprise Software

    Portfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more

    Verified email available

  • Michael DutraVerified

    Venture Debt · United States

    Health CareDatabasesWomen FoundedEnterprise Software

    Portfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more

    Verified email available

  • Nimesh ShahVerified

    Venture Debt · United States

    Health CareDatabasesWomen FoundedEnterprise Software

    Portfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more

    Verified email available

  • Raj SethVerified

    Venture Debt · United States

    Health CareDatabasesWomen FoundedEnterprise Software

    Portfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more

    Verified email available

  • Steve KuoVerified

    Venture Capital, Venture Debt · United States

    Health CareDatabasesWomen FoundedEnterprise Software

    Portfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more

    Verified email available

  • Thomas HarrisVerified

    Venture Debt · United States

    Health CareDatabasesWomen FoundedEnterprise Software

    Portfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more

    Verified email available

  • Geert

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Holger Reithinger

    Venture Capital, Investor · Germany

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more

    Contact details available

  • Juliette Audet

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Martien van Osch

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more

    Contact details available

  • Rogier Rooswinkel

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Wouter Joustra

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Asiya Giniatullina

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Bonnie van Wilgenburg

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Carlo Incerti

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Cristy Barnes

    Venture Debt · United States

    Health CareDatabasesWomen FoundedEnterprise Software

    Portfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more

    Contact details available

  • John Eggbeer

    Venture Capital, Venture Debt · United States

    Health CareDatabasesWomen FoundedEnterprise Software

    Portfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more

    Contact details available

  • Kevin Zeidan

    Venture Debt · United States

    Health CareDatabasesWomen FoundedEnterprise Software

    Portfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more

    Contact details available

  • Kristen Kosofsky

    Venture Capital, Venture Debt · United States

    Health CareDatabasesWomen FoundedEnterprise Software

    Portfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more

    Contact details available

  • Sander van Deventer

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Seth Meyer

    Venture Debt · United States

    Health CareDatabasesWomen FoundedEnterprise Software

    Portfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more

    Contact details available

  • Vincent van Houten

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Wade Lin

    Venture Debt · United States

    Health CareDatabasesWomen FoundedEnterprise Software

    Portfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more

    Contact details available

  • Amyn HassanallyVerified

    Private Equity Firm · United Kingdom

    Health CareGeneticsE-commerceCustomer Service

    Portfolio: BOOK A TIGER, UniQure

    Verified email available

  • Michael SchadVerified

    Private Equity Firm · United Kingdom

    Health CareGeneticsE-commerceCustomer Service

    Portfolio: BOOK A TIGER, UniQure

    Verified email available

  • Peter RosenVerified

    Private Equity Firm · United States

    Health CareGeneticsE-commerceCustomer Service

    Portfolio: BOOK A TIGER, UniQure

    Verified email available

  • Eric Foran

    Private Equity Firm · United States

    Health CareGeneticsE-commerceCustomer Service

    Portfolio: BOOK A TIGER, UniQure

    Contact details available

  • Francois Aguerre

    Private Equity Firm · United Kingdom

    Health CareGeneticsE-commerceCustomer Service

    Portfolio: BOOK A TIGER, UniQure

    Contact details available

  • Paige Brotherton

    Private Equity Firm · United States

    Health CareGeneticsE-commerceCustomer Service

    Portfolio: BOOK A TIGER, UniQure

    Contact details available

  • Paul Koffel

    Private Equity Firm · United Kingdom

    Health CareGeneticsE-commerceCustomer Service

    Portfolio: BOOK A TIGER, UniQure

    Contact details available

  • Paul Lanna

    Private Equity Firm · United States

    Health CareGeneticsE-commerceCustomer Service

    Portfolio: BOOK A TIGER, UniQure

    Contact details available

  • Rune Munk

    Private Equity Firm · United Kingdom

    Health CareGeneticsE-commerceCustomer Service

    Portfolio: BOOK A TIGER, UniQure

    Contact details available

Frequently asked questions

How many UniQure investors are on Angel Roster?

Angel Roster lists 38 UniQure investors. 14 of them (37%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (19), Venture Debt Lenders (15) and Private Equity Firms (15). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do UniQure investors invest in?

Among those that list a stage, the most common are Seed (7).

Where are UniQure investors based?

Most are based in the United States (19), the Netherlands (12) and the United Kingdom (6).

Which companies have UniQure investors backed?

The most-backed portfolio companies among them are Syndax Pharmaceuticals (15), Alphabet Energy (15), Zosano Pharma (15), Aldeyra Therapeutics (15) and ADMA Biologics (15).

How do I contact UniQure investors?

Create a free Angel Roster account to search and filter all 38, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.